Relapsed Grade 2/3 IDH-mutant glioma
Open
LUMOS2
Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided Therapies
Trial DetailsTrials and Research
Clinical Trials
Glioma (G3) and Glioblastoma
Completed
ACED
Acetazolamide plus Dexamethasone versus dexamethasone alone in recurrent and/or progressive HGG
Trial Details
Glioblastoma
Completed
CABARET
A randomised phase II study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme
Trial Details
Glioma (G3)
Completed
CATNON
Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial
Trial Details
Glioma (G2 and G3)
Completed
LUMOS
Low & Intermediate Grade Glioma Umbrella Study of Molecular Guided Therapies
Trial Details
Glioblastoma
Completed
NUTMEG
A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide alone in newly diagnosed Elderly patients with Glioblastoma
Trial Details
Primary malignant brain tumour, brain metastases or advanced cancer
Completed
SEED
Self-reported evaluation of the adverse effects of dexamethasone
Trial Details
Glioblastoma
Completed
VERTU
A Randomised Phase II study of Veliparib, Radiotherapy and Temozolomide in patients with unmethylated O (6)-methylguanine-DNA methyltransferase (MGMT) Glioblastoma
Trial Details
Medulloblastoma
Closed
PersoMed-I
Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I)
Trial Details